MDCX
Medicus Pharma·NASDAQ
--
--(--)
--
--(--)
MDCX Filings
Filing Date
Form Description
Form Type
2026-02-05
Form EFFECT - Notice of Effectiveness
2026-02-05 ·
Form EFFECT - Notice of Effectiveness
2026-01-30
Form S-3 - Registration statement under Securities Act of 1933
2026-01-30 ·
Form S-3 - Registration statement under Securities Act of 1933
2026-01-12
Form DRS - Draft Registration Statement
2026-01-12 ·
Form DRS - Draft Registration Statement
2026-01-05
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-05 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-02
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-01-02 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-01-02
Form EFFECT - Notice of Effectiveness
2026-01-02 ·
Form EFFECT - Notice of Effectiveness
2025-12-30
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-30 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-30
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-30 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-30
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-30 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-30
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-30 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
